Breaking News Instant updates and real-time market news.

LH

LabCorp

$157.73

-0.28 (-0.18%)

, ETFC

E-Trade

$47.61

-0.07 (-0.15%)

10:41
10/30/18
10/30
10:41
10/30/18
10:41

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. LabCorp (LH) downgraded to Hold from Buy at Argus with analyst Jasper Hellweg saying the company is faced with pressure from "lower lab testing payment rates mandated by the Protecting Access to Medicaid Act of 2014" along with business disruptions and the impact of acquisitions which resulted in lowers margins for the quarter. 2. E-Trade (ETFC) downgraded to Outperform from Strong Buy at Raymond James with analyst Patrick O'Shaughnessy saying the recent board decision not to sell the business and remain a standalone company takes a sales scenario off the table. The analyst remains positive on shares ans believes there is plenty of upside as management executes on its operating plan. 3. Southwest (LUV) downgraded to Underweight from Neutral at JPMorgan while United Continental (UAL) and Spirit Airlines (SAVE) downgraded to Neutral from Overweight. 4. Flex (FLEX) downgraded to Hold from Buy at Argus with analyst Jim Kelleher citing the expected impact from the "shutdown of Mexican operations with key customer Nike (NKE), which he expects to be fully unwound," as well as the retirement of the company CEO Mike McNamara who had presided over the company's business expansion. 5. Elevate Credit (ELVT) downgraded to Market Perform from Outperform at JMP Securities and William Blair. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

LH

LabCorp

$157.73

-0.28 (-0.18%)

ETFC

E-Trade

$47.61

-0.07 (-0.15%)

UAL

United Continental

$85.33

0.4 (0.47%)

SAVE

Spirit Airlines

$52.58

0.47 (0.90%)

LUV

Southwest

$47.96

0.04 (0.08%)

FLEX

Flex

$7.26

0.32 (4.61%)

ELVT

Elevate Credit

$4.36

-2.025 (-31.72%)

  • 30

    Oct

  • 05

    Nov

  • 06

    Nov

LH LabCorp
$157.73

-0.28 (-0.18%)

10/30/18
ARGS
10/30/18
DOWNGRADE
ARGS
Hold
LabCorp downgraded to Hold from Buy at Argus
Argus analyst Jasper Hellweg downgraded LabCorp (LH) to Hold from Buy after its Q3 earnings miss and a cut in FY18 guidance. The analyst notes that the company is faced with pressure from "lower lab testing payment rates mandated by the Protecting Access to Medicaid Act of 2014" along with business disruptions and the impact of acquisitions which resulted in lowers margins for the quarter. Hellweg further cites LabCorp's loss of "status as the exclusive national provider of laboratory services to UnitedHealthcare (UNH)" to rival Quest Diagnostics (DGX). In spite of these short-term challenges, the analyst also maintains a positive outlook for LabCorp on a long-term basis, adding that he would "consider an upgrade if the stock stabilized at the support level of $147 per share."
10/25/18
ADAM
10/25/18
DOWNGRADE
Target $162
ADAM
Hold
LabCorp downgraded to Hold ahead of "bridge year" at Canaccord
As reported previously, Canaccord analyst Mark Massaro downgraded LabCorp to Hold from Buy. The analyst cited accelerating reimbursement pressure from PAMA, expected share and profit losses, some contractual changes in managed care, and a disappointing outcome in the ACLA vs. HHS lawsuit. He calls 2019 a "bridge year" and moved to the sidelines. Massaro lowered his price target to $162 from $195 on LabCorp shares.
10/25/18
10/25/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. UPS (UPS) downgraded to Neutral from Buy at BofA/Merrill with analyst Ken Hoexter saying Q3 margins deteriorated more than expected with international falling 140bps year-over-year to 16.6%, the lowest level since 2015, and domestic falling 100bps year-over-year to 9.5%, the worst level since 2009. 2. Illinois Tool Works (ITW) downgraded to Neutral from Buy at Seaport Global with analyst Walk Liptak saying Illinois Tool Works is being negatively impacted by pockets of slowing international end markets and slower international auto production. 3. STMicroelectronics (STM) downgraded to Underperform from Outperform at Baird with analyst Tristan Gerra saying the company's lead times remain significantly elevated versus analog/MCU peers, indicating further downside, and expects a "significant" worsening in Q1 2019 quarter-over-quarter revenue comps. 4. Ambev (ABEV) downgraded to Underperform from Neutral at BofA/Merrill and to Underweight from Neutral at JPMorgan. 5. LabCorp (LH) downgraded to Hold from Buy at Canaccord with analyst Mark Massaro citing accelerating reimbursement pressure from PAMA, expected share and profit losses, some contractual changes in managed care, and a disappointing outcome in the ACLA vs. HHS lawsuit. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/30/18
ARGS
10/30/18
DOWNGRADE
ARGS
Hold
LabCorp downgraded to Hold from Buy at Argus
ETFC E-Trade
$47.61

-0.07 (-0.15%)

10/19/18
LEHM
10/19/18
NO CHANGE
Target $60
LEHM
Overweight
E-Trade price target lowered to $60 from $65 at Barclays
Barclays analyst Jeremy Campbell lowered his price target for E-Trade Financial to $60 after the company unveiled a strategy to go at it alone. The company's growth over the prior two years and future prospects check the necessary boxes to keep the board confident that an independent E-Trade will return greater shareholder value than a sale, Campbell tells investors in a research note. The analyst says that while he questions that premise, E-Trade's near-term growth prospects keep him upbeat on its earnings power. He keeps an Overweight rating on E-Trade.
10/30/18
10/30/18
DOWNGRADE
Target $64

Outperform
E-Trade downgraded to Outperform, sale off the table, says Raymond James
As previously reported, Raymond James downgraded E-Trade to Outperform from Strong Buy and maintained a $64 price target. Analyst Patrick O'Shaughnessy said the recent board decision not to sell the business and remain a standalone company takes a sales scenario off the table. The analyst remains positive on shares ans believes there is plenty of upside as management executes on its operating plan.
10/30/18
RAJA
10/30/18
DOWNGRADE
RAJA
Outperform
E-Trade downgraded to Outperform from Strong Buy at Raymond James
10/19/18
WELS
10/19/18
NO CHANGE
WELS
Outperform
Wells says E-Trade outlook should overcome disappointment over lack of M&A
Wells Fargo analyst Christopher Harris believes E-Trade's combination of better than expected Q3 results, significant capital actions, and guidance toward a path to "much higher" EPS, along with the recent weakness in the shares, should be enough to overcome any lingering disappointments about the lack of M&A. The company's target for mid-teens EPS growth over the next five years in conjunction with higher profitability are much better than consensus expectations, said Harris, who keeps an Outperform rating on E-Trade shares.
UAL United Continental
$85.33

0.4 (0.47%)

10/18/18
10/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nike (NKE) upgraded to Outperform from Perform at Oppenheimer with analyst Brian Nagel saying Nike represents an "already dominant, legacy global brand that is now aggressively embracing the power of digital to enhance most facets of its business." 2. United Continental (UAL) upgraded to Outperform from Neutral at Macquarie and to Overweight from Equal Weight at Stephens. 3. Generac (GNRC) upgraded to Neutral from Sell at Goldman Sachs with analyst Jerry Revich saying the company's organic growth outlook is improving amid rising power disturbances. 4. Proteostasis (PTI) upgraded to Outperform from Sector Perform at RBC Capital with analyst Brian Abrahams citing an "impressive" set of data from its phase 2 cystic fibrosis doublet trial. 5. Safe Bulkers (SB) upgraded to Outperform from In Line at Evercore ISI with analyst Jonathan Chappell saying the disconnect between dry bulk equity prices and spot rates continues to widen due to global trade/macro fears. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/30/18
JPMS
10/30/18
DOWNGRADE
Target $95
JPMS
Neutral
United Continental downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jamie Baker downgraded United Continental Holdings to Neutral and lowered his price target for the shares to $95 from $98.
10/30/18
JPMS
10/30/18
NO CHANGE
JPMS
JPMorgan downgrades three airlines, upgrades JetBlue to Overweight
JPMorgan analyst Jamie Baker continues to believe that a "trading trifecta" has formed for U.S. Airlines in investors' favor. The case for industry margin expansion remains the best we've seen in four years, and most stocks are within 10% of their autumnal lows, "suggesting seasonal trade-winds may lift equities as they often do," Baker tells investors in a research note. He thinks the industry remains on a path towards margin expansion for the first time since 2014 amid lower year-over-year capacity, "robust" demand, "disciplinary" fuel, and no immediate risk to labor cost assumptions. After making changes to his estimates and price targets, Baker downgraded United Continental (UAL) and Spirit Airlines (SAVE) to Neutral from Overweight, downgraded Southwest Airlines (SAVE) to Underweight from Neutral, and upgraded JetBlue Airways (JBLU) to Overweight from Neutral. Southwest and United entered the year as underperformers, but appear poised to potentially exit as winners, says Baker. From here, he'd rather focus on the "names that haven't worked than pound the table on the two that have." For Southwest, the analyst does not envision significant downside potential, but rather views the stock as "stalled at current valuation levels until such time a trajectory towards higher margins can better be established." Meanwhile, JetBlue is the "cheapest" of the domestic airlines and its target multiple is the lowest, Baker says. He sees over 20% upside potential in the shares.
10/18/18
10/18/18
UPGRADE

Outperform
United Continental upgraded to Outperform following strong results at Macquarie
As previously reported, Macquarie upgraded United Continental to Outperform from Neutral following the Q3 report and guidance. Analyst Susan Donofrio said United's execution on its hub re-banking program is evident in strong results, and its fuel capture rate is leading peers. The analyst views United's valuation as attractive and raised its price target to $102 from $91.
SAVE Spirit Airlines
$52.58

0.47 (0.90%)

10/30/18
JPMS
10/30/18
DOWNGRADE
Target $59
JPMS
Neutral
Spirit Airlines downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jamie Baker downgraded Spirit Airlines to Neutral while raising his price target for the shares to $59 from $51.
10/26/18
IMPC
10/26/18
NO CHANGE
Target $90
IMPC
Outperform
Spirit Airlines price target raised to $90 from $72 at Imperial Capital
Imperial Capital analyst Michael Derchin raised his price target for Spirit Airlines to $90 after the company indicated that Q4 TRASM is expected to increase to 6%, well ahead of expectations. The analyst believes investors are "significantly underestimating" Spirit's earnings potential considering "moderate capacity growth, positive industry trends, robust ancillary revenues, and operational improvements." He keeps an Outperform rating on the shares following the Q3 earnings report.
10/11/18
IMPC
10/11/18
NO CHANGE
Target $72
IMPC
Outperform
Spirit Airlines price target raised to $72 from $69 at Imperial Capital
Imperial Capital analyst Michael Derchin raised his price target for Spirit Airlines to $72 after the company said yesterday that its Q3 TRASM is expected to increase to 5.5% versus 2%-3% previously, due to a strong industry pricing environment, improved yield management, and strategic reallocation of capacity. Spirit is likely to offset higher fuel prices through fiscal 2019 due to decelerating capacity growth, positive industry trends, robust ancillary revenue growth, and operational improvements, Derchin tells investors in a research note. He keeps an Outperform rating on the shares.
LUV Southwest
$47.96

0.04 (0.08%)

10/30/18
JPMS
10/30/18
DOWNGRADE
Target $52
JPMS
Underweight
Southwest downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Jamie Baker downgraded Southwest Airlines to Underweight and lowered his price target for the shares to $52 from $63.
10/26/18
IMPC
10/26/18
NO CHANGE
Target $56
IMPC
In-Line
Southwest price target lowered to $56 from $66 at Imperial Capital
Imperial Capital analyst Michael Derchin lowered his price target for Southwest Airlines to $56 and maintains an In-Line rating on the shares following yesterday's Q3 results. The company indicated fiscal 2019 CASM ex-fuel is expected to increase 3% due to necessary investments throughout the business, Derchin tells investors in a research note. He believes Southwest is likely to face margin pressures in fiscal 2019 from higher costs and unit revenue headwinds from its Hawaii operation.
09/27/18
IMPC
09/27/18
NO CHANGE
Target $66
IMPC
In-Line
Southwest price target raised to $66 from $60 at Imperial Capital
Imperial Capital analyst Michael Derchin raised his price target for Southwest Airlines to $66 and maintains an In-Line rating on the shares. Southwest is likely to benefit from lower industry capacity and potentially higher domestic fares to offset higher fuel prices, Derchin tells investors in a research note. He believes, however, that the stock is fairly valued.
FLEX Flex
$7.26

0.32 (4.61%)

10/30/18
ARGS
10/30/18
DOWNGRADE
ARGS
Flex downgraded to Hold from Buy at Argus
Argus analyst Jim Kelleher downgraded Flex (FLEX) to Hold after its "disappointing" Q2 results and "weak" Q3 guidance revealed last week. The analyst also cites the expected impact from the "shutdown of Mexican operations with key customer Nike (NKE), which he expects to be fully unwound", as well as the retirement of the company CEO Mike McNamara who had presided over the company's business expansion. Kelleher adds that the loss of Nike compounds lost business from other high-profile clients, including toymaker Lego as well as numerous mobile device makers.
10/26/18
NEED
10/26/18
DOWNGRADE
NEED
Hold
Flex downgraded to Hold from Buy at Needham
As reported earlier, Needham analyst Sean Hannan downgraded Flex to Hold from Buy after its Q2 results, saying the quarter's "numerous issues" included the end of its parternership with Nike (NKE), retirement of the CEO, challenges in India expansion ramp. The analyst also calls the company's Consumer Technology Group segment a "mess" with lower operating margins, lowering his FY19 EPS view by 9c to $1.10 and FY20 view by 40c to $1.15.
10/27/18
GSCO
10/27/18
DOWNGRADE
GSCO
Neutral
Flex downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Mark Delaney downgraded Flex (FLEX) to Neutral following the company's Q2 results and announcement of a CEO change and wind down of its footwear manufacturing operations with Nike (NKE) in Mexico. While Flex's current valuation is "very inexpensive," the CEO transition and "consumer disengagement" could provide an overhang for several quarters, Delaney tells investors in a research note. Flex closed Friday down 35%, or $3.82, to $7.09.
10/30/18
ARGS
10/30/18
DOWNGRADE
ARGS
Hold
Flex downgraded to Hold from Buy at Argus
ELVT Elevate Credit
$4.36

-2.025 (-31.72%)

10/30/18
10/30/18
DOWNGRADE

Market Perform
Elevate Credit downgraded to Market Perform after 'missteps' at JMP Securities
As previously reported, JMP Securities analyst David Scharf downgraded Elevate Credit to Market Perform from Outperform after the company posted a Q3 net loss, cut its 4Q guidance, and inferred a reduction to the 2019 outlook. The company's "several missteps" have contributed to a combination of credit, volume, and cost issues behind the earnings reset, making visibility into a recovery "unusually opaque," Scharf tells investors. Since the company is indicating that full validation of its new credit scoring models will not arrive for nine months, Scharf does not see near-term catalysts, he added.
10/30/18
WBLR
10/30/18
DOWNGRADE
WBLR
Market Perform
Elevate Credit downgraded to Market Perform from Outperform at William Blair
William Blair analyst Robert Napoli downgraded Elevate Credit to Market Perform saying the company is making slower progress than he expected. The analyst is "looking for consistency" following the company's Q3 results.
10/30/18
JMPS
10/30/18
DOWNGRADE
JMPS
Market Perform
Elevate Credit downgraded to Market Perform from Outperform at JMP Securities
09/14/18
SPHN
09/14/18
NO CHANGE
SPHN
Subprime lenders weakness may be opportunity, says Stephens
Stephens analyst Vincent Caintic attributes weakness in shares of subprime consumer lenders to news that U.S. Bancorp (USB) is re-entering the small dollar, high yield lending business after Fifth Third (FITB) re-entered two months ago. However, he views the OCC's push for banks to offer small dollar loans as a positive for online lenders and notes that the recent bank announcements are for loans yielding 40%-70%, which competes against products from Regional Management (RM) and World Acceptance (WRLD) but should not impact online lenders. Subprime online lenders include Enova (ENVA) and Elevate Credit (ELVT). Other publicly traded companies in the FinTech space include LendingClub (LC) and On Deck Capital (ONDK).

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

, XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

13:26
02/16/19
02/16
13:26
02/16/19
13:26
Periodicals
Amazon a risk for almost every stock/sector, Barron's says »

Amazon (AMZN) is eating…

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

KR

Kroger

$29.50

0.54 (1.86%)

FAST

Fastenal

$62.97

0.61 (0.98%)

GWW

Grainger

$316.63

4.9 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

YETI

Yeti

$22.85

0.97 (4.43%)

13:20
02/16/19
02/16
13:20
02/16/19
13:20
Periodicals
Yeti stock has 60% upside, Barron's says »

Yeti Holdings stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

L

Loews

$46.67

0.785 (1.71%)

13:14
02/16/19
02/16
13:14
02/16/19
13:14
Periodicals
Investors can love Loews, Barron's says »

Loews is a $15B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    May

EQIX

Equinix

$421.53

1.16 (0.28%)

, COR

CoreSite Realty

$102.69

0.625 (0.61%)

13:10
02/16/19
02/16
13:10
02/16/19
13:10
Periodicals
Equinix, CoreSite Realty among stocks to play data-center boom, Barron's says »

Data-center stocks may…

EQIX

Equinix

$421.53

1.16 (0.28%)

COR

CoreSite Realty

$102.69

0.625 (0.61%)

IRM

Iron Mountain

$35.13

-0.14 (-0.40%)

INXN

Interxion

$64.65

0.81 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Mar

  • 26

    Mar

NOK

Nokia

$6.31

0.015 (0.24%)

, ERIC

Ericsson

$9.36

0.015 (0.16%)

13:07
02/16/19
02/16
13:07
02/16/19
13:07
Periodicals
A U.S. ban of Huawei may benefit Ericsson, Samsung, Barron's says »

The next salvo in the…

NOK

Nokia

$6.31

0.015 (0.24%)

ERIC

Ericsson

$9.36

0.015 (0.16%)

SSNLF

Samsung

$0.00

(0.00%)

CSCO

Cisco

$49.45

1.05 (2.17%)

JNPR

Juniper

$27.12

0.16 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

COP

ConocoPhillips

$70.13

1.04 (1.51%)

, MUR

Murphy Oil

$29.23

0.59 (2.06%)

13:00
02/16/19
02/16
13:00
02/16/19
13:00
Periodicals
Dividend investors should look to oil stocks for big yields, Barron's says »

Energy stocks aren't…

COP

ConocoPhillips

$70.13

1.04 (1.51%)

MUR

Murphy Oil

$29.23

0.59 (2.06%)

CVX

Chevron

$119.30

1.19 (1.01%)

VLO

Valero

$84.34

0.75 (0.90%)

XOM

Exxon Mobil

$77.74

1.47 (1.93%)

MRO

Marathon Oil

$17.07

0.15 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 07

    Mar

  • 18

    Mar

  • 22

    May

  • 28

    May

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

12:45
02/16/19
02/16
12:45
02/16/19
12:45
Periodicals
Protestors against NY's Amazon HQ2 got math wrong, Barron's says »

On Thursday, Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

, NDAQ

Nasdaq

$87.74

0.56 (0.64%)

12:28
02/16/19
02/16
12:28
02/16/19
12:28
Periodicals
Investors interested in U.S. cannabis companies face challenges, Barron's says »

Investors interested in…

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

NDAQ

Nasdaq

$87.74

0.56 (0.64%)

CGC

Canopy Growth

$47.54

1.49 (3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 28

    May

  • 15

    Feb

AMD

AMD

$23.68

0.55 (2.38%)

, INTC

Intel

$51.64

0.85 (1.67%)

08:43
02/16/19
02/16
08:43
02/16/19
08:43
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMD

AMD

$23.68

0.55 (2.38%)

INTC

Intel

$51.64

0.85 (1.67%)

MRVL

Marvell

$18.82

-0.37 (-1.93%)

MCHP

Microchip

$91.10

0.49 (0.54%)

MU

Micron

$41.99

-0.23 (-0.54%)

NVDA

Nvidia

$157.22

2.69 (1.74%)

QCOM

Qualcomm

$51.97

0.42 (0.81%)

TXN

Texas Instruments

$107.55

0.57 (0.53%)

TWTR

Twitter

$31.23

0.28 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 07

    Mar

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    May

  • 04

    Jun

  • 05

    Jun

AMGN

Amgen

$188.31

1.6 (0.86%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

04:55
02/16/19
02/16
04:55
02/16/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2019 ASCO Genitourinary…

AMGN

Amgen

$188.31

1.6 (0.86%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

AZN

AstraZeneca

$40.92

0.93 (2.33%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$51.64

0.81 (1.59%)

CALA

Calithera Biosciences

$5.35

0.14 (2.69%)

CLVS

Clovis

$25.44

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

EXEL

Exelixis

$22.26

-0.05 (-0.22%)

IMMU

Immunomedics

$14.23

0.225 (1.61%)

INO

Inovio

$3.70

0.01 (0.27%)

MRK

Merck

$79.84

0.9 (1.14%)

MYOV

Myovant Sciences

$21.48

0.1 (0.47%)

MYGN

Myriad Genetics

$31.41

0.53 (1.72%)

NH

NantHealth

$0.60

(0.00%)

NVS

Novartis

$89.89

0.865 (0.97%)

PFE

Pfizer

$42.41

0.45 (1.07%)

PGNX

Progenics

$4.87

0.13 (2.74%)

SGEN

Seattle Genetics

$71.48

2.92 (4.26%)

SNY

Sanofi

$42.51

0.94 (2.26%)

TYME

Tyme Technologies

$3.19

0.055 (1.76%)

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$48.17

0.84 (1.77%)

17:26
02/15/19
02/15
17:26
02/15/19
17:26
Hot Stocks
Mondelez to transfer listing of debt securities to Nasdaq »

Mondelez International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 06

    Mar

  • 28

    May

FN

Fabrinet

$55.23

0.67 (1.23%)

17:25
02/15/19
02/15
17:25
02/15/19
17:25
Hot Stocks
Fabrinet CFO sells 20K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 04

    Mar

UBER

Uber

$0.00

(0.00%)

17:24
02/15/19
02/15
17:24
02/15/19
17:24
Periodicals
Uber sues NYC over move to cap number of ride-hailing drivers, Bloomberg says »

Uber is suing New York…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$277.40

2.93 (1.07%)

17:19
02/15/19
02/15
17:19
02/15/19
17:19
Periodicals
House Democrats to probe POTUS emergency declaration, Bloomberg says »

The House Judiciary…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$277.40

2.93 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$51.71

0.25 (0.49%)

17:11
02/15/19
02/15
17:11
02/15/19
17:11
Hot Stocks
Oracle authorizes additional $12B stock buyback under existing program »

In a regulatory 8K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 06

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.